Search research articles
Contact Us
Filters
Showing results (171-180 of 196) with videos related to
Page
of 20
Sort By:
Blood
|
October 7, 2000
Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial
T Robak, J Z Bloński, M Kasznicki, et al.
British Journal of Haematology
|
February 26, 2000
Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patients
T Robak, J Z Bloński, M Kasznicki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 28, 2004
Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patients
J Czyz, R Dziadziuszko, W Knopinska-Postuszuy, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 11, 2023
Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody disease
Itay Lotan, John J Chen, Yael Hacohen, et al.
Leukemia
|
February 21, 2017
Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study
A Hochhaus, T Masszi, F J Giles, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 29, 2013
Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation
C Martínez, C Canals, B Sarina, et al.
Multiple Sclerosis and Related Disorders
|
July 25, 2025
Relapse and disability outcomes in incident MOGAD patients undergoing watchful waiting after onset
Nanthaya Tisavipat, Adi Wilf-Yarkoni, Abdullah Al-Ani, et al.
Leukemia & Lymphoma
|
June 1, 1997
Activity of 2-chlorodeoxyadenosine (Cladribine) in 2-hour intravenous infusion in 94 previously treated patients with low grade non-Hodgkin's lymphoma
T Róbak, J Gora-Tybor, E Krykowski, et al.
Leukemia
|
March 5, 2004
Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study
J Holowiecki, S Grosicki, T Robak, et al.
Leukemia & Lymphoma
|
August 1, 1996
Intermittent 2-hour intravenous infusions of 2-chlorodeoxyadenosine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lymphocytic leukemia
T Robak, M Błasinka-Morawiec, E Krykowski, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 196) with videos related to
Sort By:
Page
of 20
Blood
|
October 7, 2000
Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial
T Robak, J Z Bloński, M Kasznicki, et al.
British Journal of Haematology
|
February 26, 2000
Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patients
T Robak, J Z Bloński, M Kasznicki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 28, 2004
Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patients
J Czyz, R Dziadziuszko, W Knopinska-Postuszuy, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 11, 2023
Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody disease
Itay Lotan, John J Chen, Yael Hacohen, et al.
Leukemia
|
February 21, 2017
Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study
A Hochhaus, T Masszi, F J Giles, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 29, 2013
Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation
C Martínez, C Canals, B Sarina, et al.
Multiple Sclerosis and Related Disorders
|
July 25, 2025
Relapse and disability outcomes in incident MOGAD patients undergoing watchful waiting after onset
Nanthaya Tisavipat, Adi Wilf-Yarkoni, Abdullah Al-Ani, et al.
Leukemia & Lymphoma
|
June 1, 1997
Activity of 2-chlorodeoxyadenosine (Cladribine) in 2-hour intravenous infusion in 94 previously treated patients with low grade non-Hodgkin's lymphoma
T Róbak, J Gora-Tybor, E Krykowski, et al.
Leukemia
|
March 5, 2004
Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study
J Holowiecki, S Grosicki, T Robak, et al.
Leukemia & Lymphoma
|
August 1, 1996
Intermittent 2-hour intravenous infusions of 2-chlorodeoxyadenosine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lymphocytic leukemia
T Robak, M Błasinka-Morawiec, E Krykowski, et al.
Page
of 20